2024 summit on
atopic dermatitis
Saturday, May 11, 2024
10am–1pm ET
about the conference
The Summit on Atopic Dermatitis will seek to address an unmet need for education on the incidence of and latest therapies for AD among healthcare providers.
Join us for an in-depth discussion on the diagnosis, treatment, and latest therapies for atopic dermatitis in Canada. Meeting highlights will include communicating with patients and families, diagnosing across the skin spectrum, addressing disparities, and sun protection.
The 2024 program will be held virtually on Saturday, May 11 and will be available to attend at no charge to delegates.
learning objectives
-
Recognize manifestations of atopic dermatitis and learn how to diagnose AD in various skin tones
-
Adopt tools to more effectively treat and manage pediatric patients and advise caregivers
-
Improve ability to identify and manage common triggers of AD
-
Understand the latest available therapies for atopic dermatitis and their use cases
-
Learn about best practices for treatment and prevention of AD
conference faculty
Dr. Marissa Joseph is a board-certified pediatrician and dermatologist in Canada and the U.S. and is full-time academic faculty at the University of Toronto. She has received and has been nominated for teaching awards in both undergraduate and postgraduate medical education. She has also completed an MSc in Community Health at the Dalla Lana School of Public Health.
Dr. Joseph is the Medical Director of the Ricky Kanee Schachter Dermatology Centre at Women's College Hospital. She also works at the Hospital For Sick Children where she manages children with complex dermatologic disease in outpatient and inpatient settings, as well as a pediatric laser treatment program.
Dr. Joseph enjoys her diverse practice in general adult, pediatric, and surgical dermatology. Her clinical and research interests include inflammatory skin disorders such as psoriasis, atopic dermatitis, and hidradenitis suppurativa; genodermatoses; and equity, diversity and inclusivity.
Dr. Marissa Joseph (conference co-chair)
Dr. Neil Shear was Head of Dermatology at Sunnybrook Health Sciences Centre and is Professor Emeritus at the University of Toronto. He retired from active practice in June 2021 and continues to provide mentorship and education in dermatology. His primary academic research was in drug safety, including basic mechanisms that lead to increased risk for drug-induced harm.
Dr. Shear’s practice was considered advanced medical dermatology, with diseases of focus include atopic dermatitis, psoriasis, auto-immune blistering disease, drug-induced diseases, hidradenitis suppurativa, cutaneous lymphomas and auto-immune skin disease.
Past positions Dr. Shear has held include: President of the Canadian Dermatology Association, President of the Canadian Society of Clinical Pharmacology, President of the Canadian Professors of Dermatology, President of the Canadian Dermatology Foundation and Head of Dermatology at University of Toronto.